SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-11-179093
Filing Date
2011-06-30
Accepted
2011-06-30 17:13:05
Documents
6
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q d10qa.htm 10-Q/A 55823
2 AMENDED AND RESTATED COLLABORATION AGREEMENT-BIOGEN IDEC MA INC. dex104.htm EX-10.4 325292
3 LICENSE AGREEMENT - MILLENNIUM PHARMACEUTICALS, INC. dex105.htm EX-10.5 480051
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex313.htm EX-31.3 3061
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex314.htm EX-31.4 3262
6 GRAPHIC g204010g10v76.jpg GRAPHIC 11277
  Complete submission text file 0001193125-11-179093.txt   884339
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-51531 | Film No.: 11942867
SIC: 2834 Pharmaceutical Preparations